China Biologic Products Inc
China Biologic Products, Inc. (NASDAQ:CBPO) is a biopharmaceutical company. The Company through our indirect majority-owned People’s Republic of China subsidiaries, Shandong Taibang Biological Products Co. Ltd. (Shandong Taibang) and Guizhou Taibang Biological Products Co., Ltd. (Guizhou Taibang), and its minority-owned People’s Republic of China investee, Xi’an Huitian Blood Products Co., Ltd (Huitian), principally engaged in the research, development, manufacturing and sales of human plasma-based pharmaceutical products in China.
View in Other Languages
News
CCG Investor Relations ("CCG"), a leading US-headquartered global investor relations and strategic communications consultancy, today announced the presenting companies for 2013 China Best Ideas Investment Conference. The event will showcase some of the very best managed Chinese companies that are listed overseas and foster an open and informative dialogue with investors.
###
42,962 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 15) (Last 30 Days: 45) (Since Published: 7693)
